Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells

Figure 4 Antilipolytic action of B6V10 in human adipocytes depends on prior lipolytic activation. Lipolysis was activated by: Increasing doses of isoprenaline (A) or high dose of atrial natriuretic peptide (ANP) (B), and without or with the indicated doses of B6V10 (red symbols). Mean ± SEM of 6 determinations. Significantly different from corresponding condition without B6V10 at: ^aP < 0.05.